LPL and metabolic syndrome: The expression profile of the LPL gene was decreased by ∼0.01-fold in AF without the MetS group and by ∼0.24-fold in AF with the MetS group, as compared to an increase by ∼2.41-fold in the control group, representing a significant difference as well (Table 1).